GlassScriptPhysician profile
Elizabeth Marquez
NPI 1750677860
$2,593.48
in general payments reported to CMS, 2019-2025
18 companies · $2,187 in 2025
The $2,187 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2021: $63.27 · 2022: $44.19 · 2024: $83.09 · 2025: $2,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,445 · Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,444.97 |
| Food and Beverage | $825.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,956.21 | 2019-2025 | |
| Abbott Laboratories | $149.78 | 2025 | Proclaim |
| Dexcom, INC. | $90.00 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $85.66 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $38.79 | 2019 | |
| Lilly USA, LLC | $37.25 | 2024 | Mounjaro, Zepbound |
| Cvrx, INC. | $33.10 | 2025 | Barostim Neo System |
| Sun Pharmaceutical Industries INC. | $30.13 | 2024 | |
| Merck Sharp & Dohme LLC | $27.82 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.27 | 2021-2022 | |
| Pfizer INC. | $17.80 | 2022 | |
| Amarin Pharma, INC. | $17.07 | 2019 | |
| Exact Sciences Corporation | $15.71 | 2024 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $14.46 | 2019 | |
| Vivus LLC | $14.07 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.69 | 2019 | |
| Glaxosmithkline, LLC. | $12.39 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Marquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.